![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ERBB2IP |
Gene summary for ERBB2IP |
![]() |
Gene information | Species | Human | Gene symbol | ERBB2IP | Gene ID | 55914 |
Gene name | erbb2 interacting protein | |
Gene Alias | ERBB2IP | |
Cytomap | 5q12.3 | |
Gene Type | protein-coding | GO ID | GO:0001816 | UniProtAcc | Q96RT1 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
55914 | ERBB2IP | P9 | Human | Prostate | Tumor | 6.12e-05 | 2.12e-01 | -0.0285 |
55914 | ERBB2IP | P10 | Human | Prostate | Tumor | 1.02e-07 | 2.74e-01 | -0.0902 |
55914 | ERBB2IP | GSM5353215_PA_AUG_PB_1B_S2 | Human | Prostate | Tumor | 3.79e-09 | 8.43e-01 | 0.1557 |
55914 | ERBB2IP | GSM5353216_PA_PB1A_Pool_1_3_S50_L002 | Human | Prostate | Tumor | 9.10e-10 | 8.42e-01 | 0.159 |
55914 | ERBB2IP | GSM5353217_PA_PB1A_Pool_2_S107_L004 | Human | Prostate | Tumor | 3.83e-03 | 6.78e-01 | 0.156 |
55914 | ERBB2IP | GSM5353218_PA_PB1B_Pool_1_2_S74_L003 | Human | Prostate | Tumor | 7.60e-04 | 6.06e-01 | 0.1479 |
55914 | ERBB2IP | GSM5353220_PA_PB1B_Pool_3_S51_L002 | Human | Prostate | Tumor | 1.29e-04 | 5.49e-01 | 0.1531 |
55914 | ERBB2IP | GSM5353221_PA_PB2A_Pool_1_3_S25_L001 | Human | Prostate | Tumor | 4.72e-31 | 8.82e-01 | 0.1633 |
55914 | ERBB2IP | GSM5353222_PA_PB2B_Pool_1_3_S52_L002 | Human | Prostate | Tumor | 4.57e-21 | 6.74e-01 | 0.1608 |
55914 | ERBB2IP | GSM5353223_PA_PB2B_Pool_2_S26_L001 | Human | Prostate | Tumor | 1.19e-20 | 6.90e-01 | 0.1604 |
55914 | ERBB2IP | GSM5353224_PA_PR5186_Pool_1_2_3_S27_L001 | Human | Prostate | Tumor | 2.81e-24 | 7.50e-01 | 0.1621 |
55914 | ERBB2IP | GSM5353225_PA_PR5196-1_Pool_1_2_3_S53_L002 | Human | Prostate | Tumor | 1.19e-11 | 6.97e-01 | 0.1619 |
55914 | ERBB2IP | GSM5353226_PA_PR5196-2_Pool_1_2_3_S54_L002 | Human | Prostate | Tumor | 1.14e-06 | 6.74e-01 | 0.159 |
55914 | ERBB2IP | GSM5353227_PA_PR5199-193K_Pool_1_2_3_S55_L002 | Human | Prostate | Tumor | 7.60e-18 | 6.73e-01 | 0.1602 |
55914 | ERBB2IP | GSM5353228_PA_PR5199-640K_Pool_1_3_S108_L004 | Human | Prostate | Tumor | 2.86e-04 | 7.20e-01 | 0.1537 |
55914 | ERBB2IP | GSM5353232_PA_PR5249_T1_S3_L001 | Human | Prostate | Tumor | 9.55e-05 | 7.15e-01 | 0.1439 |
55914 | ERBB2IP | GSM5353236_PA_PR5251_T1_S7_L001 | Human | Prostate | Tumor | 5.58e-07 | 4.28e-01 | 0.1608 |
55914 | ERBB2IP | GSM5353237_PA_PR5251_T2_S8_L001 | Human | Prostate | Tumor | 1.03e-11 | 8.46e-01 | 0.1622 |
55914 | ERBB2IP | GSM5353240_PA_PR5254_T1_S15_L001 | Human | Prostate | Tumor | 2.41e-19 | 6.14e-01 | 0.1575 |
55914 | ERBB2IP | GSM5353243_PA_PR5261_T1_S23_L002 | Human | Prostate | Tumor | 9.01e-14 | 5.56e-01 | 0.1545 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa046213 | Cervix | CC | NOD-like receptor signaling pathway | 41/1267 | 186/8465 | 5.90e-03 | 1.95e-02 | 1.15e-02 | 41 |
hsa0462112 | Cervix | CC | NOD-like receptor signaling pathway | 41/1267 | 186/8465 | 5.90e-03 | 1.95e-02 | 1.15e-02 | 41 |
hsa046212 | Lung | IAC | NOD-like receptor signaling pathway | 38/1053 | 186/8465 | 1.23e-03 | 8.24e-03 | 5.47e-03 | 38 |
hsa0462111 | Lung | IAC | NOD-like receptor signaling pathway | 38/1053 | 186/8465 | 1.23e-03 | 8.24e-03 | 5.47e-03 | 38 |
hsa046214 | Oral cavity | EOLP | NOD-like receptor signaling pathway | 48/1218 | 186/8465 | 2.51e-05 | 1.31e-04 | 7.70e-05 | 48 |
hsa046215 | Oral cavity | EOLP | NOD-like receptor signaling pathway | 48/1218 | 186/8465 | 2.51e-05 | 1.31e-04 | 7.70e-05 | 48 |
hsa046216 | Oral cavity | NEOLP | NOD-like receptor signaling pathway | 39/1112 | 186/8465 | 1.79e-03 | 7.91e-03 | 4.98e-03 | 39 |
hsa046217 | Oral cavity | NEOLP | NOD-like receptor signaling pathway | 39/1112 | 186/8465 | 1.79e-03 | 7.91e-03 | 4.98e-03 | 39 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |